HSCT approach provides ‘excellent’ survival in FAMarch 2, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLMyelodysplastic Syndrome
CHMP endorses drug delivery systemMarch 1, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyRelated Issues
Expanded UCB product can stand aloneFebruary 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAMLALLMyelodysplastic Syndrome
NK-cell therapy in resistant MDS, AMLFebruary 16, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Azacitidine now available in ChinaFebruary 9, 2018AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
FDA places T-cell therapy on clinical holdFebruary 1, 2018AnemiaLeukemia, Myelodysplasia, TransplantationPediatricsTransplantation
Predicting response to AZA in MDS, CMMLJanuary 21, 2018AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome